Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilfried A M Bakker

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Pharmaceutical Patent Analyst|November 19, 2013
Innovative IPV from attenuated Sabin poliovirus or newly designed alternative seed strainsAhd Hamidi, Wilfried A M Bakker
Vaccine|April 11, 2015
sIPV process development for costs reductionYvonne E Thomassen, Wilfried A M Bakker
Expert Review of Vaccines|May 25, 2011
Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strainsPauline Verdijk, Nynke Y Rots, Wilfried A M Bakker
Biologicals : Journal of the International Association of Biological Standardization|October 11, 2016
Development of inactivated poliovirus vaccine from Sabin strains: A progress reportHiromasa Okayasu, Carolyn Sein, Ahd Hamidi, et al.
British Journal of Pharmacology|May 22, 2024
Non-coding RNAs to treat vascular smooth muscle cell dysfunctionSimon D Brown, Eftychia Klimi, Wilfried A M Bakker, et al.
Biotechnology Progress|August 21, 2014
Assessment of mass transfer and mixing in rigid lab-scale disposable bioreactors at low power input levelsGerco van Eikenhorst, Yvonne E Thomassen, Leo A van der Pol, et al.
Analytical Chemistry|May 16, 2013
Isoelectric point determination of live polioviruses by capillary isoelectric focusing with whole column imaging detectionYvonne E Thomassen, Gerco van Eikenhorst, Leo A van der Pol, et al.
Vaccine|December 17, 2013
A mucosal adjuvant for the inactivated poliovirus vaccineBenjamin P Steil, Patricia Jorquera, Janny Westdijk, et al.
Vaccine|July 25, 2019
Accelerating bioprocess development by analysis of all available data: A USP case studyDiego A Suarez-Zuluaga, Daniel Borchert, Nicole N Driessen, et al.
Bioprocess and Biosystems Engineering|October 9, 2014
Mathematical model of adherent Vero cell growth and poliovirus production in animal component free mediumRamona V Ursache, Yvonne E Thomassen, Gerco van Eikenhorst, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Pharmaceutical Patent Analyst|November 19, 2013
Innovative IPV from attenuated Sabin poliovirus or newly designed alternative seed strainsAhd Hamidi, Wilfried A M Bakker
Vaccine|April 11, 2015
sIPV process development for costs reductionYvonne E Thomassen, Wilfried A M Bakker
Expert Review of Vaccines|May 25, 2011
Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strainsPauline Verdijk, Nynke Y Rots, Wilfried A M Bakker
Biologicals : Journal of the International Association of Biological Standardization|October 11, 2016
Development of inactivated poliovirus vaccine from Sabin strains: A progress reportHiromasa Okayasu, Carolyn Sein, Ahd Hamidi, et al.
British Journal of Pharmacology|May 22, 2024
Non-coding RNAs to treat vascular smooth muscle cell dysfunctionSimon D Brown, Eftychia Klimi, Wilfried A M Bakker, et al.
Biotechnology Progress|August 21, 2014
Assessment of mass transfer and mixing in rigid lab-scale disposable bioreactors at low power input levelsGerco van Eikenhorst, Yvonne E Thomassen, Leo A van der Pol, et al.
Analytical Chemistry|May 16, 2013
Isoelectric point determination of live polioviruses by capillary isoelectric focusing with whole column imaging detectionYvonne E Thomassen, Gerco van Eikenhorst, Leo A van der Pol, et al.
Vaccine|December 17, 2013
A mucosal adjuvant for the inactivated poliovirus vaccineBenjamin P Steil, Patricia Jorquera, Janny Westdijk, et al.
Vaccine|July 25, 2019
Accelerating bioprocess development by analysis of all available data: A USP case studyDiego A Suarez-Zuluaga, Daniel Borchert, Nicole N Driessen, et al.
Bioprocess and Biosystems Engineering|October 9, 2014
Mathematical model of adherent Vero cell growth and poliovirus production in animal component free mediumRamona V Ursache, Yvonne E Thomassen, Gerco van Eikenhorst, et al.
Pageof 4